Use of maximum slope images generated from dynamic contrast-enhanced MRI to detect locally recurrent prostate carcinoma after prostatectomy: A practical approach

American Journal of Roentgenology

Volumn 198, Issue 3, 2012, Pages

  Boonsirikamchai, Piyaporn ^a   Kaur, Harmeet ^a   Kuban, Deborah A ^a   Jackson, Edward ^a   Hou, Ping ^a   Choi, Haesun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dynamic contrast enhanced MRI; Local; Prostate cancer; Recurrence; Slope image

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEMORAL ARTERY; FOLLOW UP; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RECURRENT CANCER; TUMOR BIOPSY; TUMOR VOLUME;

AGED; BIOPSY; CONTRAST MEDIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84857843400     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6387     Document Type: Article

References (23)

1. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society, 2010
2. Scattoni V, Montorsi F, Picchio M, et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int 2004; 93:680-688 (Pubitemid 38375788)
3. Catalona WJ, Smith DS. Cancer recurrence and survival rate after anatomic retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998; 160:2428-2434
4. Nudell DM, Wefer AE, Hricak H, et al. Imaging for recurrence prostate cancer. Radiol Clin North Am 2000; 38:213-229
5. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003; 169:517-523 (Pubitemid 36132976)
6. Foster LS, Jajodia P, Fournier G Jr, et al. The value of prostatic specific antigen and transrectal ultrasound guided biopsy in detecting the prostate fossa recurrence following radical prostatectomy. J Urol 1993; 149:1024-1028 (Pubitemid 23133763)
7. Jhaveri FM, Klein EA. How to explore the patient with a rising PSA after radical prostatectomy: defining local versus systemic failure. Semin Urol Oncol 1999; 17:130-134 (Pubitemid 29380639)
8. Scattoni V, Roscigno M, Raber M, Consonni P, Da Pozzo L, Rigatti P. Biopsy of the vesico-urethral anastomosis after radical prostatectomy: when and how. Eur Urol Suppl 2002; 1:89-95 (Pubitemid 36056450)
9. Connolly JA, Shinohara K, Presti JC Jr, Carroll PR. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 1996; 47:225-231 (Pubitemid 26075278)
10. Casciani E, Polettini E, Carmenini E, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR 2008; 190:1187-1192 (Pubitemid 351684918)
11. Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol 1999; 17:1155
12. Roscigno M, Cozzarini C, Scattoni V, et al. Prognostic factors of radiotherapy (RT) efficacy in patients with serum prostate specific antigen (PSA) elevation after radical prostatectomy. Eur Urol Suppl 2003; 2:23
13. Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 1997; 157:2323-2328 (Pubitemid 27208715)
14. Ferrer FA, Miller LJ, Andrawis RI, et al. Angiogenesis and prostate cancer in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998; 51:161-167 (Pubitemid 28092530)
15. Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 2007; 63:335-350 (Pubitemid 47321040)
16. Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 2005; 62:140-147 (Pubitemid 40096780)
17. Jackson ASN, Resinsberg SA, Sohaib A, et al. Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol 2009; 82:148-156
18. Silverman JM, Krebs TL. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR 1997; 168:379-385 (Pubitemid 27051968)
19. Sella T, Schwartz LH, Swindle PW, et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004; 231:379-385 (Pubitemid 38552892)
20. Sciarra A, Panebianco V, Salciccia S, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008; 54:589-600
21. Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW. Analysis of prostate DCEMRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Invest Radiol 2009; 44:577-584
22. Moul JW. Prostate specific antigen only progression of prostate cancer. J Urol 2000; 163:1632-1642 (Pubitemid 30366704)
23. Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol 1999; 162:1337-1340 (Pubitemid 29428575)